PCOS Healthcare Trends · Evergreen explainer

Insulin resistance in PCOS/PMOS, in plain language

If the word “metabolic” in the new name PMOS feels abstract, insulin resistance is a large part of what it points to. It is also one of the most misunderstood parts of this condition: central to how clinicians explain PCOS/PMOS, and yet not one of the tests used to diagnose it. This piece separates the mechanism from the screening — what insulin does, what changes when cells respond less well to it, and what follow-up the international guideline actually recommends.

First, what insulin does on a normal day

Insulin is a hormone made by the pancreas. After you eat, sugar (glucose) from food enters the blood. Insulin is the signal that helps cells take that sugar in to use or store, so blood sugar stays in a steady range. Our glossary gives the short version: insulin resistance is when the body’s cells do not respond well to insulin, so the body makes extra insulin.

What “resistance” means, step by step

  1. Cells respond less strongly. Muscle, liver, and fat cells hear insulin’s signal less clearly than usual.
  2. The pancreas compensates. It makes more insulin, and for a while that extra amount can keep blood sugar in the normal range. That is why a normal blood-sugar result does not, by itself, describe how hard the system is working to keep it normal.
  3. Extra insulin reaches other tissues. Clinicians and researchers describe two connected effects that matter in PCOS/PMOS: higher insulin can signal the ovaries to produce more androgens, and it can lower a liver protein (SHBG) that normally keeps some androgen inactive — so more androgen is free to act. Androgen excess is one of the three features in the diagnosis rule explained in our diagnosis explainer.
  4. Over time, blood sugar can rise. If compensation stops keeping up, glucose results can move into the ranges clinicians call prediabetes and then type 2 diabetes. That progression is a risk, not a certainty, and it is the reason screening — below — is built into follow-up for this condition at all.

Three things insulin resistance is not

Why there is no routine “insulin resistance test” in the guideline

This surprises many patients, because fasting insulin and calculated scores such as HOMA-IR are discussed a lot online. The 2023 International Evidence-based Guideline is explicit on the point, in its own wording: insulin resistance is a key feature of the condition’s biology, but currently available insulin tests have limited clinical value and are not recommended in routine care. One reason summaries of the guideline give is standardisation — insulin assays are not standardised across laboratories the way glucose tests are, so the same sample can read differently in different places, and there is no single agreed cut-off.

That does not mean the metabolic side is ignored. It means the guideline screens the part that can be measured reliably and acted on over time: glucose status itself.

What screening usually looks like instead

As the guideline’s recommendations are summarised by its home program at Monash and in the published guideline:

The U.S. Centers for Disease Control and Prevention makes the same connection in plain terms on its PCOS page, noting that more than half of women with PCOS develop type 2 diabetes by age 40 in the data it cites — a statistic about a population, not a prediction about any one person, and a further reason the screening above is routine rather than optional.

Which clinician handles which part

Metabolic follow-up is shared ground, which is exactly why it can fall between chairs:

The useful question is not which one is “the” PCOS clinician — it is who, in your own care, owns the metabolic re-check date, so it does not quietly lapse.

What this means when you are finding care

A provider page that mentions metabolic screening, glucose follow-up, or working alongside a dietitian or endocrinologist is describing the part of care the new PMOS name was chosen to surface. You can search the directory for PCOS/PMOS-focused providers, browse by state — for example, the Florida listings page — and use the plain-language glossary for terms such as insulin resistance, A1C, and metabolic syndrome before a visit.

Questions worth asking your provider

Sources

Looking for care? Find a PCOS/PMOS-focused provider or browse by state.

This article is general information published by the PMOS Directory. It is not medical advice and is not a substitute for professional medical advice, diagnosis, or treatment. It does not describe what any treatment does for any person, and it is not a recommendation for or against any treatment, product, or provider. Always seek the advice of your physician or other qualified health provider with any questions about a medical condition. If this is an emergency, call 911.